PLXP - PLx Pharma Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
4.35
+0.10 (+2.35%)
As of 9:52AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close4.25
Open4.35
Bid4.25 x 800
Ask4.70 x 1100
Day's Range4.35 - 4.40
52 Week Range3.20 - 9.41
Volume1,045
Avg. Volume12,289
Market Cap37.976M
Beta-1.38
PE Ratio (TTM)N/A
EPS (TTM)-2.19
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.00
Trade prices are not sourced from all markets
  • GlobeNewswire9 days ago

    PLx Pharma Inc. to Present at JMP Securities Life Sciences Conference

    HOUSTON, June 11, 2018-- PLx Pharma Inc., a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 mg and Aspertec™ 81 mg, announced today that ...

  • GlobeNewswirelast month

    PLx Pharma Inc. Reports First Quarter 2018 Results

    HOUSTON, May 11, 2018-- PLx Pharma Inc., a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 mg and Aspertec™ 81 mg, announced today certain ...

  • ACCESSWIRE2 months ago

    Blog Exposure - Arcturus Initiates Lawsuit against Former CEO Joseph Payne for Misconduct and Violations of Federal Disclosure

    Stock Monitor: PLx Pharma Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 24, 2018 / Active-Investors.com has just released a free research report on Arcturus Therapeutics Ltd (NASDAQ: ARCT ) ("Arcturus"). ...

  • GlobeNewswire3 months ago

    PLx Pharma Inc. Reports Fourth Quarter and Full Year 2017 Results

    HOUSTON, March 23, 2018-- PLx Pharma Inc., a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 mg and Aspertec™ 81 mg, announced today ...

  • Is PLx Pharma Inc’s (PLXP) Balance Sheet Strong Enough To Weather A Storm?
    Simply Wall St.7 months ago

    Is PLx Pharma Inc’s (PLXP) Balance Sheet Strong Enough To Weather A Storm?

    PLx Pharma Inc (NASDAQ:PLXP) is a small-cap stock with a market capitalization of USD $59.68M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies,Read More...

  • ACCESSWIRE7 months ago

    PLx Pharma, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / November 10, 2017 / PLx Pharma, Inc. (NASDAQ: PLXP ) will be discussing their earnings results in their Q3 Earnings Call to be held on Friday, November 10, 2017 at 8:30 AM Eastern ...

  • Associated Press7 months ago

    PLx Pharma reports 3Q loss

    The Houston-based company said it had a loss of 44 cents per share. The biotechnology company posted revenue of $62,300 in the period. Its adjusted revenue was $62,000. PLx Pharma shares have decreased ...

  • Associated Press10 months ago

    PLx Pharma reports 2Q loss

    On a per-share basis, the New York-based company said it had a loss of 36 cents. Losses, adjusted for non-recurring gains, came to 54 cents per share. The biotechnology company posted revenue of $376,000 ...